Bionano Genomics, Inc. Common Stock (NASDAQ: BNGO) last traded at $1.41, up 3.31% on the session. The quote above updates while this page is open; the figures below are drawn from Bionano Genomics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Bionano Genomics, Inc. Common Stock trades on NASDAQ under the ticker BNGO. Its market capitalisation is $16.55 million.
Valuation measures for Bionano Genomics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $16.55M |
|---|---|
| Enterprise value | $28.80M |
| Price / sales | 0.55 |
| Price / book | 0.52 |
| Beta | 1.49 |
Trailing-twelve-month figures tagged in Bionano Genomics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $30.18M |
|---|---|
| Net income (TTM) | -$32.16M |
| EPS (TTM) | -$3.11 |
| Gross margin | 47.51% |
| Operating margin | -106.67% |
| Return on equity | -101.76% |
| Cash | $3.73M |
Range and volume for BNGO over the past 52 weeks.
| 52-week high | $2.23 |
|---|---|
| 52-week low | $1.00 |
| Volume | 82.3K |
| Average volume | 902.5K |
| Previous close | $1.36 |
Invest a chosen dollar amount in Bionano Genomics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell BNGO.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.